About 200 reports

The Global Patient-controlled Analgesic Pumps Market size is expected to reach $614.5 Million by 2027, rising at a market growth of 9.6% CAGR during the forecast period. Patient-controlled analgesia (PCA) pumps are considered as the devices that are effective & helpful for patients in controlling their pain through the regulation of the amount...

  • Analgesic
  • APAC
  • Europe
  • North America
  • Health Provider Density
  • Cancer Survival Rate

Major players in the analgesics market are Bayer Healthcare, Pfizer, Sanofi, Johnson & Johnson, Novartis AG, GlaxoSmithKline PLC., Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb and Eli Lilly and Company. The global analgesics market is expected to grow from $104.72 billion in 2021 to $110.08 billion in 2022 at a...

  • Analgesic
  • United States
  • United Kingdom
  • Chronic Disease Prevalence
  • Analgesic Medicine Sales

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Analgesic
  • Opioid
  • World
  • Chronic Disease Prevalence
  • Cancer Incidence

Major players in the analgesics or analgesic drugs market are Smith & Nephew, Stryker, Zimmer Biomet, B. Braun Melsungen and Wright Medical Group. The global analgesics market is expected to grow from $71.6 billion in 2020 to $72.49 billion in 2021 at a compound annual growth rate (CAGR) of 1.2%. The change in growth trend is mainly...

  • Orthopedic Prosthesis
  • Analgesic
  • United States
  • Analgesic Medicine Sales

Abstract: - Global Endometriosis Drugs Market to Reach $2.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Endometriosis Drugs estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at aCAGR of 2.8% over the period 2020-2027. Hormone...

  • Genitourinary System Disease
  • Pharmaceutical
  • Hormone
  • Analgesic
  • World
  • China
  • United States

Abstract: - Global Pain Management Devices Market to Reach $7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Pain Management Devices estimated at US$4.5 Billion in the year 2020, is projected to reach a revised size of US$7 Billion by 2027, growing at a CAGR of 6.4% over the analysis period 2020-2027....

  • Analgesic
  • Injectable Delivery
  • World
  • China
  • United States

The global analgesics market reached a value of US$ 49.02 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 64.59 Billion by 2027, exhibiting a CAGR of 4.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of...

  • Analgesic
  • World
  • Internet Penetration
  • Generic Drugs Market Share

A recent market study published on the Opioid Analgesics Market offers a global industry analysis for 2016-2020 and an opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the opioid...

  • Opioid
  • World

Abstract: - Global Over the Counter (OTC) Drugs Market to Reach $210.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Over the Counter (OTC) Drugs estimated at US$146.3 Billion in the year 2020, is projected to reach a revised size of US$210.3 Billion by 2027, growing at a CAGR of 5.3% over the analysis...

  • Dermatology
  • Analgesic
  • Influenza
  • World
  • China
  • United States

Analgesics Global Market Report 2020-30: Covid 19 Implications and Growth covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for analgesics due to COVID 19. Description: Where...

  • Analgesic
  • World

Asia Pacific pain management devices market is expected to reach US$ 1,869.84 million by 2027 from US$ 969.30 million in 2019. The market is anticipated to grow at a CAGR of 8.7% from 2020 to 2027. Factors such as rise in incidence of chronic diseases and pain and increase in geriatric population are anticipated to boost the growth of the...

  • Analgesic
  • APAC
  • Chronic Disease Prevalence
  • Cancer Incidence

Europe pain management devices market is expected to reach US$ 2,001.54 million by 2027 from US$ 1,109.71 million in 2019. The market is anticipated to grow at a CAGR of 7.8% from 2020 to 2027. The growth of the Europe pain management devices market is estimated to grow owing to the key factors such as rising of chronic pain incidences...

  • Analgesic
  • Europe
  • Chronic Disease Prevalence
  • Cancer Mortality

North America pain management devices market is expected to reach US$ 3,804.26 million by 2027 from US$ 2,031.40 million in 2019. The market is anticipated to grow with a CAGR of 8.3% from 2020 to 2027. The growth of the North America pain management devices market is estimated to grow owing to the key factors such as growing Incidences...

  • Analgesic
  • United States
  • North America
  • Drug Approval
  • Chronic Disease Prevalence

The global pain management devices market is expected to reach US$ 8,388.67 million in 2027 from US$ 4,527.31 million in 2019. The market is estimated to grow with a CAGR of 8.1% from 2020 to 2027. Increasing chronic pain incidences, rising product launches and growing geriatric population are the major factors driving the growth of the...

  • Analgesic
  • APAC
  • World
  • United States
  • North America
  • Europe
  • Central America
  • Chronic Disease Prevalence
  • Cancer Incidence

The South and Central America pain management devices market is expected to reach US$ 477.32 million by 2027 from US$ 276.75 million in 2019. The market is anticipated to grow with a CAGR of 7.1% from 2020 to 2027. The South and Central America pain management devices market is expected to grow due to rising incidence of chronic pain and...

  • Analgesic
  • Central America
  • Brazil
  • Argentina
  • Chronic Disease Prevalence
  • Drug Approval

The global pain management market was valued at USD 79,448.93 million in 2021, and it is projected to be worth USD 120,781.07 million, registering a CAGR of 7.39% during the forecast period of 2021-2027. The COVID-19 pandemic has impacted the healthcare systems across the world. The health agencies are engaged in containing coronavirus...

  • Analgesic
  • World
  • Health Expenditure
  • Elderly Population

Pain Management Devices Market by Type (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices) and Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028 The global pain management...

  • Analgesic
  • World
  • APAC

U.S. Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis,...

  • Chronic Pain
  • Analgesic
  • United States
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

Gulf Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis,...

  • Chronic Pain
  • Analgesic
  • Oman
  • Saudi Arabia
  • United Arab Emirates
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

The Global Pain Management Devices Market size is expected to reach $6.3 billion by 2026, rising at a market growth of 8.5% CAGR during the forecast period. Pain management is a branch of medical science that relieves patients with chronic pain from their suffering. Acute pain has a sudden onset of action, while chronic pain persists for a...

  • Analgesic
  • Chronic Pain
  • World

The North America analgesics market reached a value of US$ 20.4 Billion in 2018. An analgesic or painkiller is any member of the group of drugs used for achieving analgesia or relief from pain. Analgesic drugs act in different ways on the peripheral and central nervous systems. They mostly include paracetamol or acetaminophen, the nonsteroidal...

  • Analgesic
  • North America

Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute Appendicitis,...

  • Chronic Pain
  • Analgesic
  • APAC
  • World
  • Europe
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

LATAM Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drugs, Antidepressant Drugs, Opioids, Non-Narcotics, and Analgesics), Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, Fibromyalgia, Bone Fracture, Muscle Sprain/Strain, Acute...

  • Chronic Pain
  • Chronic Disease
  • Analgesic
  • Latin America
  • Chronic Disease Prevalence
  • Health Expenditure

Pain Management Drugs Market by Drug Class, (NSAIDS, Anesthetics, Anticonvulsant, Anti-Migraine Drug, Antidepressant Drugs, Opioids, and Non-Narcotic Analgesics) and Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Pain, Post-Operative Pain, Migraine, and Fibromyalgia): Global Opportunity Analysis and Industry Forecast,...

  • Analgesic
  • Chronic Pain
  • Opioid
  • World
  • APAC
  • Chronic Disease Prevalence
  • Surgical Procedures Performed

Anti-Inflammatory Therapeutics Market by Drug Class (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, and Biologics), Indication Type (Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), and Other Anti-inflammatory Diseases): Global Opportunity Analysis and Industry...

  • Analgesic
  • World

Major players in the pain management devices and therapies market are Abbott Laboratories, AstraZeneca, Pfizer, Boston Scientific Corporation and GlaxoSmithKline PLC. The global pain management devices and therapies market is expected to grow from $4.07 billion in 2020 to $4.49 billion in 2021 at a compound annual growth rate (CAGR)...

  • Analgesic
  • World
  • United States
  • China
  • APAC
  • Brazil
  • Medical Devices Sales
  • Drug Approval

The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain.Key application areas explored in the research include neuropathic pain, migrane, post-surgical pain, cancer pain, chronic pain and migraine. The research encompasses technological advances across Nav1.7 inhibitors,...

  • Chronic Pain
  • Analgesic
  • Pharmaceutical
  • Biomaterial
  • Cell Therapy

The global cold pain therapy market size is projected to reach USD 2.0 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 4.4% during the forecast period. Factors such as increasing prevalence of arthritis and the rising number of sports injuries are the key factors boosting the demand for cold pain therapy products for the management...

  • Analgesic
  • World
  • United States
  • North America
  • APAC
  • Latin America
  • Health Expenditure
  • Sports Participation Rate

Premenstrual Syndrome Treatment Market by Drug Type (Analgesics, Antidepressants, Oral Contraceptives & Ovarian Suppression Agents, and Others), Type (Prescription and OTC), and Distribution Channel (Hospital Pharmacy, Drug Store & Retail Pharmacy, Online Providers): Global Opportunity Analysis and Industry Forecast, 2019–2026 The...

  • Pharmacy
  • In-Store Retail
  • Contraceptive
  • Analgesic
  • Antidepressant
  • World
  • APAC
  • Europe

Pain Management Devices Market by Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps, and Ablation Devices) and Application (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026 The global pain...

  • Analgesic
  • Chronic Pain
  • World
  • APAC
  • Europe